202 related articles for article (PubMed ID: 19799973)
1. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
Visser S; Yang X
Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
[TBL] [Abstract][Full Text] [Related]
2. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
3. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses.
Samuel S; Bernstein LR
Mol Carcinog; 2004 Jan; 39(1):34-60. PubMed ID: 14694446
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
Zhang J; Smolen GA; Haber DA
Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
[TBL] [Abstract][Full Text] [Related]
6. Comparative expression of zebrafish lats1 and lats2 and their implication in gastrulation movements.
Chen CH; Sun YH; Pei DS; Zhu ZY
Dev Dyn; 2009 Nov; 238(11):2850-9. PubMed ID: 19842174
[TBL] [Abstract][Full Text] [Related]
7. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
[TBL] [Abstract][Full Text] [Related]
8. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers.
Gray D; Jubb AM; Hogue D; Dowd P; Kljavin N; Yi S; Bai W; Frantz G; Zhang Z; Koeppen H; de Sauvage FJ; Davis DP
Cancer Res; 2005 Nov; 65(21):9751-61. PubMed ID: 16266996
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of radiation response genes in primary human fibroblasts.
Kis E; Szatmári T; Keszei M; Farkas R; Esik O; Lumniczky K; Falus A; Sáfrány G
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1506-14. PubMed ID: 17069989
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis modulates gene expression profile in skeletal muscle.
Shah VO; Dominic EA; Moseley P; Pickett G; Fleet M; Ness S; Raj DS
Am J Kidney Dis; 2006 Oct; 48(4):616-28. PubMed ID: 16997058
[TBL] [Abstract][Full Text] [Related]
11. Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis.
Huang C; Liu LY; Li ZF; Wang P; Ni L; Song LP; Xu DH; Song TS
Cell Biol Int; 2008 Sep; 32(9):1081-90. PubMed ID: 18539490
[TBL] [Abstract][Full Text] [Related]
12. Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells.
Chen S; Wang G; Makrigiorgos GM; Price BD
Biochem Biophys Res Commun; 2004 May; 317(4):1037-44. PubMed ID: 15094373
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes that are linked with optineurin expression using a combined RNAi--microarray approach.
Weisschuh N; Alavi MV; Bonin M; Wissinger B
Exp Eye Res; 2007 Oct; 85(4):450-61. PubMed ID: 17663987
[TBL] [Abstract][Full Text] [Related]
14. LATS tumor suppressor: a new governor of cellular homeostasis.
Visser S; Yang X
Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
[TBL] [Abstract][Full Text] [Related]
15. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype.
Irby RB; Malek RL; Bloom G; Tsai J; Letwin N; Frank BC; Verratti K; Yeatman TJ; Lee NH
Cancer Res; 2005 Mar; 65(5):1814-21. PubMed ID: 15753379
[TBL] [Abstract][Full Text] [Related]
16. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D
FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366
[TBL] [Abstract][Full Text] [Related]
17. Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A.
Nihrane A; Sezgin G; Dsilva S; Dellorusso P; Yamamoto K; Ellis SR; Liu JM
Blood Cells Mol Dis; 2009; 42(1):85-91. PubMed ID: 19014892
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
[TBL] [Abstract][Full Text] [Related]
19. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.
Siripurapu V; Meth J; Kobayashi N; Hamaguchi M
J Mol Biol; 2005 Feb; 346(1):83-9. PubMed ID: 15663929
[TBL] [Abstract][Full Text] [Related]
20. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.
Yang X; Yu K; Hao Y; Li DM; Stewart R; Insogna KL; Xu T
Nat Cell Biol; 2004 Jul; 6(7):609-17. PubMed ID: 15220930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
